NO165223C - Fremgangsmaate for fremstilling av et stabilt antibakterielt lyofilisat. - Google Patents

Fremgangsmaate for fremstilling av et stabilt antibakterielt lyofilisat.

Info

Publication number
NO165223C
NO165223C NO843313A NO843313A NO165223C NO 165223 C NO165223 C NO 165223C NO 843313 A NO843313 A NO 843313A NO 843313 A NO843313 A NO 843313A NO 165223 C NO165223 C NO 165223C
Authority
NO
Norway
Prior art keywords
lyophilizate
bacterial
preparing
procedure
stable anti
Prior art date
Application number
NO843313A
Other languages
English (en)
Norwegian (no)
Other versions
NO843313L (no
NO165223B (no
Inventor
Kazuhiro Shima
Masayoshi Inoue
Takayuki Tsukada
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO843313L publication Critical patent/NO843313L/no
Publication of NO165223B publication Critical patent/NO165223B/no
Publication of NO165223C publication Critical patent/NO165223C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO843313A 1983-08-22 1984-08-20 Fremgangsmaate for fremstilling av et stabilt antibakterielt lyofilisat. NO165223C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58153938A JPS6045514A (ja) 1983-08-22 1983-08-22 安定な抗菌性凍結乾燥製剤

Publications (3)

Publication Number Publication Date
NO843313L NO843313L (no) 1985-02-25
NO165223B NO165223B (no) 1990-10-08
NO165223C true NO165223C (no) 1991-01-30

Family

ID=15573358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843313A NO165223C (no) 1983-08-22 1984-08-20 Fremgangsmaate for fremstilling av et stabilt antibakterielt lyofilisat.

Country Status (20)

Country Link
US (1) US4616083A (fi)
EP (1) EP0134568B1 (fi)
JP (1) JPS6045514A (fi)
KR (1) KR910004575B1 (fi)
AR (1) AR242390A1 (fi)
AT (1) ATE38774T1 (fi)
CA (1) CA1231896A (fi)
DE (2) DE134568T1 (fi)
DK (1) DK163032C (fi)
ES (1) ES8505815A1 (fi)
FI (1) FI83476C (fi)
GB (1) GB2145333B (fi)
GR (1) GR80147B (fi)
IE (1) IE57587B1 (fi)
IL (1) IL72731A (fi)
NO (1) NO165223C (fi)
NZ (1) NZ209111A (fi)
PT (1) PT79093B (fi)
SU (1) SU1433390A3 (fi)
ZA (1) ZA846104B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
ES2177522T3 (es) * 1990-11-06 2002-12-16 Nippon Shinyaku Co Ltd Preparacion liofilizada y su procedimiento de realizacion.
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
AU2003241675A1 (en) * 2002-06-21 2004-01-06 Shionogi And Co., Ltd. Medicinal cephem compound composition for injection
KR101314500B1 (ko) * 2012-12-28 2013-10-07 제일약품주식회사 안정성이 개선된 옥사세펨 제제 및 그 제조방법
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101935186B1 (ko) 2014-09-04 2019-01-03 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류를 함유하는 제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA919593A (en) * 1969-03-31 1973-01-23 Nippon Kayaku Kabushiki Kaisha Process for manufacturing a preparation containing finely divided chloramphenicol palmitate
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS5762284A (en) * 1980-10-01 1982-04-15 Sumitomo Chem Co Ltd Stabilizing method
JPS59139385A (ja) * 1982-12-23 1984-08-10 Shionogi & Co Ltd フルオロメチルチオオキサセフアロスポリン

Also Published As

Publication number Publication date
IE57587B1 (en) 1993-01-13
NZ209111A (en) 1987-02-20
FI843261A (fi) 1985-02-23
KR850001687A (ko) 1985-04-01
ES535654A0 (es) 1985-06-16
DK399684D0 (da) 1984-08-21
ATE38774T1 (de) 1988-12-15
SU1433390A3 (ru) 1988-10-23
IE842072L (en) 1985-02-22
NO843313L (no) 1985-02-25
IL72731A (en) 1988-04-29
DE3475268D1 (en) 1988-12-29
PT79093B (en) 1986-08-14
EP0134568B1 (en) 1988-11-23
FI83476C (fi) 1991-07-25
US4616083A (en) 1986-10-07
CA1231896A (en) 1988-01-26
FI843261A0 (fi) 1984-08-17
GB2145333A (en) 1985-03-27
EP0134568A1 (en) 1985-03-20
DK163032C (da) 1992-06-15
GB2145333B (en) 1987-01-07
ES8505815A1 (es) 1985-06-16
JPS6045514A (ja) 1985-03-12
DK399684A (da) 1985-02-23
AR242390A1 (es) 1993-03-31
FI83476B (fi) 1991-04-15
GB8420296D0 (en) 1984-09-12
ZA846104B (en) 1985-03-27
DK163032B (da) 1992-01-13
NO165223B (no) 1990-10-08
IL72731A0 (en) 1984-11-30
KR910004575B1 (ko) 1991-07-06
JPH0370688B2 (fi) 1991-11-08
GR80147B (en) 1984-12-18
DE134568T1 (de) 1985-08-29
PT79093A (en) 1984-09-01

Similar Documents

Publication Publication Date Title
FI845096A0 (fi) Foerfarande foer framstaellning av en polarisationsbevarande optisk fiber.
NO881044L (no) Fremgangsmaate for fremstilling av en tiazepinforbindelse.
NO842394L (no) Fremgangsmaate ved fremstilling av 13alfa-alkylgonamer.
FI842848A (fi) Lock och behaollare och dessa beroerande foerbaettringar.
NO884058D0 (no) Fremgangsmaate for fremstilling av cefemforbindelser.
FI882827A (fi) Foerfarande och anordning foer framstaellning av burkaemne av stympad pyramidform.
FI880118A (fi) Foerfarande foer fodring av roerledningar och passager.
NO165223C (no) Fremgangsmaate for fremstilling av et stabilt antibakterielt lyofilisat.
FI843879A0 (fi) Foerfarande och anordning foer testning och underhaoll av databehandlingssystem.
FI852443A0 (fi) Anordning foer framstaellning av en roerformig behaollarhylsa.
NO883339D0 (no) Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser.
ES538935A0 (es) Un procedimiento de preparar un compuesto de fenol-sulfonato o fenolcarboxilato
FI840572A (fi) Foerfarande och anordning foer erhaollande och kompensering av en industrirobots banavvikelse.
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
FI844800L (fi) Foerfarande foer foerpackning av mynt och en plastmaterialfilm foer att verkstaella foerfarandet.
FI841552A0 (fi) Centraliserat datauppsamlingssystem.
FI840408A (fi) Lock foer behaollare.
IT8422796A0 (it) Gruppo filatoio-incannatoio.
FI840261A (fi) Substituerade pyrrolidinonderivat och foerfarande foer deras framstaellning.
ES533691A0 (es) Procedimiento de preparar 2,9-dihidrofuranos
NO162816C (no) Fremgangsmaate for fremstilling av et dialkanolyksybenzylidendialkanoat.
NO164471C (no) Analogifremgangsmaate for fremstilling av 1-fenoksy-3-hydroksyindolylalkylamino-3-propanoler.
NO165489C (no) Fremgangsmaate for fremstilling av en tib2 gjenstand.
FI871805A (fi) Anordning foer avlaegsnande av ett omslag kring en parallellepipedformad artikel.
NO900286D0 (no) Fremgangsmaate for fremstilling av en pyridobenzodiazepinforbindelser.